Inequities in Rural and Urban Health Care Utilization Among Individuals Diagnosed With Inflammatory Bowel Disease: A Retrospective Population-Based Cohort Study From Saskatchewan, Canada
- PMID: 37025513
- PMCID: PMC10071297
- DOI: 10.1093/jcag/gwac015
Inequities in Rural and Urban Health Care Utilization Among Individuals Diagnosed With Inflammatory Bowel Disease: A Retrospective Population-Based Cohort Study From Saskatchewan, Canada
Abstract
Background: Rural dwellers with inflammatory bowel disease (IBD) face barriers to accessing specialized health services. We aimed to contrast health care utilization between rural and urban residents diagnosed with IBD in Saskatchewan, Canada.
Methods: We completed a population-based retrospective study from 1998/1999 to 2017/2018 using administrative health databases. A validated algorithm was used to identify incident IBD cases aged 18+. Rural/urban residence was assigned at IBD diagnosis. Outpatient (gastroenterology visits, lower endoscopies, and IBD medications claims) and inpatient (IBD-specific and IBD-related hospitalizations, and surgeries for IBD) outcomes were measured after IBD diagnosis. Cox proportional hazard, negative binomial, and logistic models were used to evaluate associations adjusting by sex, age, neighbourhood income quintile, and disease type. Hazard ratios (HR), incidence rate ratios (IRR), odds ratios (OR), and 95% confidence intervals (95% CI) were reported.
Results: From 5,173 incident IBD cases, 1,544 (29.8%) were living in rural Saskatchewan at IBD diagnosis. Compared to urban dwellers, rural residents had fewer gastroenterology visits (HR = 0.82, 95% CI: 0.77-0.88), were less likely to have a gastroenterologist as primary IBD care provider (OR = 0.60, 95% CI: 0.51-0.70), and had lower endoscopies rates (IRR = 0.92, 95% CI: 0.87-0.98) and more 5-aminosalicylic acid claims (HR = 1.10, 95% CI: 1.02-1.18). Rural residents had a higher risk and rates of IBD-specific (HR = 1.23, 95% CI: 1.13-1.34; IRR = 1.22, 95% CI: 1.09-1.37) and IBD-related (HR = 1.20, 95% CI: 1.11-1.31; IRR = 1.23, 95% CI: 1.10-1.37) hospitalizations than their urban counterparts.
Conclusion: We identified rural-urban disparities in IBD health care utilization that reflect rural-urban inequities in the access to IBD care. These inequities require attention to promote health care innovation and equitable management of patients with IBD living in rural areas.
Keywords: Crohn’s disease; Health care inequities; Health services; Inflammatory bowel disease; Rural health; Ulcerative colitis.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S23-S34. doi: 10.1093/jcag/gwad008. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674493 Free PMC article. Review.
-
Health care utilization differences between First Nations people and the general population with inflammatory bowel disease: a retrospective cohort study from Saskatchewan, Canada.CMAJ Open. 2022 Nov 1;10(4):E964-E970. doi: 10.9778/cmajo.20220118. Print 2022 Oct-Dec. CMAJ Open. 2022. PMID: 36319027 Free PMC article.
-
Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018. Clin Epidemiol. 2018. PMID: 30519110 Free PMC article.
-
Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults.J Can Assoc Gastroenterol. 2020 Aug 21;4(4):186-193. doi: 10.1093/jcag/gwaa028. eCollection 2021 Aug. J Can Assoc Gastroenterol. 2020. PMID: 34337319 Free PMC article.
-
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.Inflamm Bowel Dis. 2022 Dec 1;28(12):1904-1914. doi: 10.1093/ibd/izac021. Inflamm Bowel Dis. 2022. PMID: 35230420 Free PMC article.
Cited by
-
Decade-Long Trends in Hospitalization, Outcomes, and Emergency Department Visits for Inflammatory Bowel Diseases in the United States, 2010 to 2020.Cureus. 2025 Jan 24;17(1):e77941. doi: 10.7759/cureus.77941. eCollection 2025 Jan. Cureus. 2025. PMID: 39996174 Free PMC article.
-
Patient and Public Involvement in Inflammatory Bowel Disease Research-A Scoping Review.J Can Assoc Gastroenterol. 2023 Dec 14;7(2):137-148. doi: 10.1093/jcag/gwad054. eCollection 2024 Apr. J Can Assoc Gastroenterol. 2023. PMID: 38596798 Free PMC article.
-
Exploring the Experiences of Virtual Inflammatory Bowel Disease Care in Saskatchewan.Can J Nurs Res. 2024 Mar;56(1):95-108. doi: 10.1177/08445621231219299. Epub 2023 Dec 7. Can J Nurs Res. 2024. PMID: 38062657 Free PMC article.
-
The Lived Experience of Adults With Inflammatory Bowel Disease in Rural Areas: Phenomenological Study.Nurs Health Sci. 2025 Mar;27(1):e70058. doi: 10.1111/nhs.70058. Nurs Health Sci. 2025. PMID: 39928987 Free PMC article.
-
The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S23-S34. doi: 10.1093/jcag/gwad008. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674493 Free PMC article. Review.
References
-
- Coward S, Clement F, Benchimol EI, et al. . Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology. 2019;156:1345–53.e4. - PubMed
LinkOut - more resources
Full Text Sources